CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0.0%

Compliant submissions 0

Incompliant submissions 1

Total trials 1

My Organizations' Clinical Trials

Showing 200 of 361 entries

View as:

A Study to Investigate the Process by Which ABT-614 is Absorbed, Distributed, Metabolized and Eliminated in Humans

Phase: N/A Priority: Normal

NCT ID: NCT00959816 Org: User:

Start: 08/31/09 End: - Due: -

Study of Real Clinical Practice to Evaluate the Effects of Oral Dydrogesterone for Treatment of Confirmed Endometriosis

Phase: N/A Priority: Normal

NCT ID: NCT03690765 Org: User:

Start: 09/27/18 End: 05/29/20 Due: 05/29/21

Remission in Subjects With Crohn's Disease, Open Label Extension

Phase: N/A Priority: Normal

NCT ID: NCT01070303 Org: User:

Start: 08/31/02 End: 12/31/08 Due: 12/31/09

Safety and Efficacy of Zemplar Capsule in Reducing Serum IPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)

Phase: N/A Priority: Normal

NCT ID: NCT00048438 Org: User:

Start: 02/28/02 End: - Due: -

Pharmacokinetic and Exploratory Biomarker Study of ABT-126 in Healthy Volunteers

Phase: N/A Priority: Normal

NCT ID: NCT00912431 Org: User:

Start: 06/30/09 End: - Due: -

Evaluation of Effectiveness of the Treatment After Repeated Administration of Klacid®SR

Phase: N/A Priority: Normal

NCT ID: NCT01130883 Org: User:

Start: 02/28/10 End: 07/31/10 Due: 07/31/11

Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease

Phase: N/A Priority: Normal

NCT ID: NCT00195715 Org: User:

Start: 09/30/04 End: 12/31/08 Due: 12/31/09

This is a Single Ascending Dose Tolerance Study

Phase: N/A Priority: Normal

NCT ID: NCT01133574 Org: User:

Start: 02/28/10 End: 07/31/10 Due: 07/31/11

A Study of Effectiveness and Safety of Tumor Necrosis Factor (TNF) Inhibitors in Patients With Moderate to Severe Psoriasis

Phase: N/A Priority: Normal

NCT ID: NCT01126619 Org: User:

Start: 05/31/10 End: 09/30/11 Due: 09/30/12

A Long Term Roll-over Study to Investigate the Efficacy and Safety of Adalimumab Given Long-term to Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal

NCT ID: NCT00233571 Org: User:

Start: 06/30/00 End: 06/30/06 Due: 06/30/07

Compliance to Synagis (Palivizumab) Under Daily Pediatrician´s Conditions in Premature Infants 33 - 35 wGA

Phase: N/A Priority: Normal

NCT ID: NCT01077271 Org: User:

Start: 10/31/08 End: 05/31/11 Due: 05/31/12

The Safety and Effectiveness of Clarithromycin Plus Zidovudine or Dideoxyinosine in the Treatment of Mycobacterium Avium Complex (MAC) Infections in Children With AIDS

Phase: N/A Priority: Normal

NCT ID: NCT00000971 Org: User:

Start: - End: - Due: -

Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects During the Maintenance Phase of Bipolar Illness

Phase: N/A Priority: Normal

NCT ID: NCT00071253 Org: User:

Start: 07/31/03 End: - Due: -

Evaluation of the Effectiveness, Compliance of Ibuprofen in a Sustained Release Form in the Treatment of Egyptian Osteoarthritic Patients

Phase: N/A Priority: Normal

NCT ID: NCT01226095 Org: User:

Start: 06/30/10 End: 11/30/10 Due: 11/30/11

A Study to Evaluate the Safety and Efficacy of Paricalcitol Capsules in Reducing Serum Intact Parathyroid Hormone Levels in End Stage Renal Disease Subjects on Peritoneal Dialysis

Phase: N/A Priority: Normal

NCT ID: NCT00646035 Org: User:

Start: 01/31/02 End: - Due: -

Testosterone Treatment for Hypogonadal Men

Phase: N/A Priority: Normal

NCT ID: NCT00433199 Org: User:

Start: 02/28/07 End: 04/30/08 Due: 04/30/09

A Study of Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis

Phase: N/A Priority: Normal

NCT ID: NCT00647491 Org: User:

Start: 02/29/04 End: 08/31/05 Due: 08/31/06

Cost Utility Analyses of Adalimumab Treatment in Patients With Rheumatoid Arthritis (RA)

Phase: N/A Priority: Normal

NCT ID: NCT01078116 Org: User:

Start: 11/30/07 End: 06/30/10 Due: 06/30/11

Study in Healthy Adults to Evaluate the Bioavailability of Two Test Tablet Formulations of ABT-450

Phase: N/A Priority: Normal

NCT ID: NCT01091649 Org: User:

Start: 02/28/10 End: 04/30/10 Due: 04/30/11

Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Antiretroviral Naïve Subjects

Phase: N/A Priority: Normal

NCT ID: NCT00043966 Org: User:

Start: 07/31/02 End: - Due: -

A Multiple-Dose Pharmacokinetic Interaction Study Between ABT-335, Atorvastatin and Ezetimibe

Phase: N/A Priority: Normal

NCT ID: NCT00681525 Org: User:

Start: 04/30/08 End: - Due: -

Treatment of the Human Anti-TNF Monoclonal Antibody Adalimumab in Moderate to Severe Crohn's Disease With Previous Exposure to Infliximab (CHOICE)

Phase: N/A Priority: Normal

NCT ID: NCT00338650 Org: User:

Start: 06/30/06 End: 05/31/07 Due: 05/31/08

Phase I Safety Study of Anti-HIV Immune Serum Globulin (Human)

Phase: N/A Priority: Normal

NCT ID: NCT00002036 Org: User:

Start: - End: - Due: -

Study of ABT-267 in Both Healthy Volunteers and Hepatitis C Virus (HCV) Genotype 1 Infected Subjects

Phase: N/A Priority: Normal

NCT ID: NCT01181427 Org: User:

Start: 08/31/10 End: 01/31/12 Due: 01/31/13

A Study Evaluating the Bioavailability of Two Formulations of Linifanib and Food Effect on Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal

NCT ID: NCT01506934 Org: User:

Start: 10/31/11 End: 01/31/12 Due: 01/31/13

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
A Study to Investigate the Process by Which ABT-614 is Absorbed, Distributed, Metabolized and Eliminated in Humans	NCT00959816	Abbott	user2@example.com	None	2009-08-31	-	-	-	-	2025-07-14
Study of Real Clinical Practice to Evaluate the Effects of Oral Dydrogesterone for Treatment of Confirmed Endometriosis	NCT03690765	Abbott	user2@example.com	None	2018-09-27	2020-05-29	2021-05-29	-	-	2025-07-14
Remission in Subjects With Crohn's Disease, Open Label Extension	NCT01070303	Abbott	user2@example.com	None	2002-08-31	2008-12-31	2009-12-31	-	-	2025-07-14
Safety and Efficacy of Zemplar Capsule in Reducing Serum IPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)	NCT00048438	Abbott	user2@example.com	None	2002-02-28	-	-	-	-	2025-07-14
Pharmacokinetic and Exploratory Biomarker Study of ABT-126 in Healthy Volunteers	NCT00912431	Abbott	user2@example.com	None	2009-06-30	-	-	-	-	2025-07-14
Evaluation of Effectiveness of the Treatment After Repeated Administration of Klacid®SR	NCT01130883	Abbott	user2@example.com	None	2010-02-28	2010-07-31	2011-07-31	-	-	2025-07-14
Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease	NCT00195715	Abbott	user2@example.com	None	2004-09-30	2008-12-31	2009-12-31	-	-	2025-07-14
This is a Single Ascending Dose Tolerance Study	NCT01133574	Abbott	user2@example.com	None	2010-02-28	2010-07-31	2011-07-31	-	-	2025-07-14
A Study of Effectiveness and Safety of Tumor Necrosis Factor (TNF) Inhibitors in Patients With Moderate to Severe Psoriasis	NCT01126619	Abbott	user2@example.com	None	2010-05-31	2011-09-30	2012-09-30	-	-	2025-07-14
A Long Term Roll-over Study to Investigate the Efficacy and Safety of Adalimumab Given Long-term to Patients With Rheumatoid Arthritis	NCT00233571	Abbott	user2@example.com	None	2000-06-30	2006-06-30	2007-06-30	-	-	2025-07-14
Compliance to Synagis (Palivizumab) Under Daily Pediatrician´s Conditions in Premature Infants 33 - 35 wGA	NCT01077271	Abbott	user2@example.com	None	2008-10-31	2011-05-31	2012-05-31	-	-	2025-07-14
The Safety and Effectiveness of Clarithromycin Plus Zidovudine or Dideoxyinosine in the Treatment of Mycobacterium Avium Complex (MAC) Infections in Children With AIDS	NCT00000971	Abbott	user2@example.com	Incompliant	-	-	-	2025-07-01	-	2025-07-14
Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects During the Maintenance Phase of Bipolar Illness	NCT00071253	Abbott	user2@example.com	None	2003-07-31	-	-	-	-	2025-07-14
Evaluation of the Effectiveness, Compliance of Ibuprofen in a Sustained Release Form in the Treatment of Egyptian Osteoarthritic Patients	NCT01226095	Abbott	user2@example.com	None	2010-06-30	2010-11-30	2011-11-30	-	-	2025-07-14
A Study to Evaluate the Safety and Efficacy of Paricalcitol Capsules in Reducing Serum Intact Parathyroid Hormone Levels in End Stage Renal Disease Subjects on Peritoneal Dialysis	NCT00646035	Abbott	user2@example.com	None	2002-01-31	-	-	-	-	2025-07-14
Testosterone Treatment for Hypogonadal Men	NCT00433199	Abbott	user2@example.com	None	2007-02-28	2008-04-30	2009-04-30	-	-	2025-07-14
A Study of Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis	NCT00647491	Abbott	user2@example.com	None	2004-02-29	2005-08-31	2006-08-31	-	-	2025-07-14
Cost Utility Analyses of Adalimumab Treatment in Patients With Rheumatoid Arthritis (RA)	NCT01078116	Abbott	user2@example.com	None	2007-11-30	2010-06-30	2011-06-30	-	-	2025-07-14
Study in Healthy Adults to Evaluate the Bioavailability of Two Test Tablet Formulations of ABT-450	NCT01091649	Abbott	user2@example.com	None	2010-02-28	2010-04-30	2011-04-30	-	-	2025-07-14
Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Antiretroviral Naïve Subjects	NCT00043966	Abbott	user2@example.com	None	2002-07-31	-	-	-	-	2025-07-14
A Multiple-Dose Pharmacokinetic Interaction Study Between ABT-335, Atorvastatin and Ezetimibe	NCT00681525	Abbott	user2@example.com	None	2008-04-30	-	-	-	-	2025-07-14
Treatment of the Human Anti-TNF Monoclonal Antibody Adalimumab in Moderate to Severe Crohn's Disease With Previous Exposure to Infliximab (CHOICE)	NCT00338650	Abbott	user2@example.com	None	2006-06-30	2007-05-31	2008-05-31	-	-	2025-07-14
Phase I Safety Study of Anti-HIV Immune Serum Globulin (Human)	NCT00002036	Abbott	user2@example.com	None	-	-	-	-	-	2025-07-14
Study of ABT-267 in Both Healthy Volunteers and Hepatitis C Virus (HCV) Genotype 1 Infected Subjects	NCT01181427	Abbott	user2@example.com	None	2010-08-31	2012-01-31	2013-01-31	-	-	2025-07-14
A Study Evaluating the Bioavailability of Two Formulations of Linifanib and Food Effect on Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid Tumors	NCT01506934	Abbott	user2@example.com	None	2011-10-31	2012-01-31	2013-01-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance